Alcon Inc

Overview

Alcon Inc (Alcon) develops and manufactures devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for prevention and cure of blindness and different eye diseases. Alcon develops its pipeline products through collaboration with institutions, medical innovators, research advisors, and academic thought leaders. The company has operations in the Americas, Europe, the Middle East, and Africa and Asia Pacific. Alcon is headquartered in Geneva, Switzerland.
Key Stats
Address
Rue Louis-d'Affry 6, FRIBOURG, Switzerland
Headquarters

Switzerland

Website
www.alcon.com
No of Employees

23,655

Industry

Medical Equipment

Ticker Symbol & Exchange​

ALC [SWF]

Revenue (2020)

$6,833 m

-9% (2020 vs 2019)
Net Income (2020)

$-531 m

19.1% (2020 vs 2019)
Net Profit Margin

-8 %

11.1% (2020 vs 2019)
Market Cap *

$42,361 m

EPS *

$-1.1

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Alcon IncJohnson & JohnsonEssilorLuxottica SAKonica Minolta Inc
Key Information
Headquarters Switzerland United States of America France Japan
Headquarter City FRIBOURG NEW BRUNSWICK CHARENTON-LE-PONT CHIYODA-KU
Headquarter State/Province - New Jersey - Tokyo
No. of Employees 23,655 134,500 144,512 40,979
Entity Type Public Public Public Public

Products & Services

Alcon develops, manufactures, and markets vision care products and ophthalmic surgical devices. The company’s key products include the following:

Products
  • Vision Care:
  • Contact Lenses
  • Ocular Health Products
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • Commercial Dose- Injectables
  • Commercial Dose- Other
  • Etiam Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Timothy C. Stonesifer Chief Financial Officer; Senior Vice President Senior Management 2019 - Mr. Timothy C. Stonesifer has been the Senior Vice President and the Chief Financial Officer (CFO) of Alcon since April...
David J. Endicot Director; Chief Executive Officer Executive Board 2018 55 Mr. David J. Endicot has been the Director of the Board and Chief Executive Officer of Alcon Inc since July...
Sue-Jean Lin Chief Information Officer; Senior Vice President Senior Management 2018 - Ms. Sue-Jean Lin has been the Chief Information Officer (CIO) and Senior Vice President of Operational Strategy of Alcon Inc...
Rajkumar Narayanan Chief Transformation Officer; Senior Vice President - Operational Strategy Senior Management 2018 56 Mr. Rajkumar Narayanan has been the Chief Transformation Officer and Senior Vice President of Operational Strategy of Alcon since 2018....
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Acquisitions/Mergers/Takeovers In April, the company agreed to acquire the US commercialization rights to Simbrinza 1%/0.2% from…
2021 New Products/Services In April, the company launched Systane Hydration Multi-Dose Preservative-Free (MDPF) lubricant eye drops.
2020 New Products/Services In March, the company launched SYSTANE MyEyes, a new patient support program.
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Alcon Research Ltd

Address

6201 South Freeway, Fort Worth
United States of America

Telephone

1 817 2930450

Website

www.alcon.com
Alcon Pharma GmbH

Address

Blankreutestrasse 1, Freiburg im Breisgau
Germany

Telephone

49 761 13040

Website

www.de.alcon.com
Alcon Singapore Manufacturing Pte Ltd

Address

19 Tuas South Avenue 14, Far West - Jurong, Singapore
Singapore

Telephone

65 65 978200

Website

www.alcon.com
Alcon Cusi SA

Address

C.Camil Fabra, 58, El Masnou
Spain

Telephone

34 901 120303

Website

www.alcon.es
Alcon Laboratories Philippines Inc

Address

3rd Floor, LGI Building, Ortigas Avenue, Greenhills, San Juan
Philippines

Telephone

63 272 13956

Alcon Portugal-Produtos e Equipamentos Oftalmologicos Lda

Address

Quinta da Fonte - Edificio D. Sancho l, Rua dos Malhoes, Nº4 - Piso 3º, Porto Salvo, Paco d'Arcos
Portugal

Telephone

351 21 4400300

PowerVision Inc

Address

298 Harbor Boulevard, Belmont
United States of America

Telephone

650 620 9948

Website

powervisionlens.com
Alcon Pharmaceuticals LTD. Taiwan Branch

Address

4th Floor, 119,PAO-CHUNG RD, HSIN-TIEN
Taiwan

Telephone

886 2 29172468

Website

www.alcon.com.tw

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
28 Apr 2021 Alcon to Acquire US Rights to Simbrinza from Novartis for USD355 Million Asset Transaction Alcon Inc Novartis AG
18 May 2020 Alcon Prices Private Placement of 2.6% Notes Due 2030 for USD750 Million Debt Offering Alcon Inc
16 Sep 2019 Alcon Raises USD500 Million in Private Placement of 3.8% Notes Due 2049 Debt Offering Alcon Inc
16 Sep 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
16 Sep 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
18 Mar 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

2.7K

Active Jobs

1.6K

Posted

1.6K

Closed

Job Trends

Latest Jobs

Job title Company Country
In Vivo Research Scientist, Ophthalmology Alcon Inc United States
PROS Business Leader- Mid-Atlantic- Remote Alcon Inc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar